Ticker
URGNCompany Name
UROGEN PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -123.53M | -14.36% | $ 860.05M |
3/31/2025 | $ -107.39M | -20.91% | $ 513.64M |
12/31/2024 | $ -97.06M | -21.23% | $ 457.26M |
9/30/2024 | $ -96.38M | -18.66% | $ 516.52M |
6/30/2024 | $ -86.02M | -13.65% | $ 630.03M |
3/31/2024 | $ -82.47M | -17.47% | $ 472.22M |
12/31/2023 | $ -76.57M | -15.66% | $ 488.97M |
9/30/2023 | $ -85.28M | -23.66% | $ 360.52M |
6/30/2023 | $ -85.65M | -13.33% | $ 642.3M |
3/31/2023 | $ -89.62M | -30.77% | $ 291.29M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for UROGEN PHARMA LTD is calculated as follows: FCF [ $ -111.88M ] / Market Cap [ $ 549.9M ]
(=) FCF Yield [ -20.35% ]
Minimum
Mar 31, 2022
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.58% |
median | 3.22% |
std | 11.38% |